Q1 Earnings Forecast for RCKT Issued By William Blair

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities research analysts at William Blair issued their Q1 2026 EPS estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Thursday, February 27th. William Blair analyst S. Corwin forecasts that the biotechnology company will earn ($0.27) per share for the quarter. The […]

Leave a Reply

Your email address will not be published.

Previous post Jay-Z’s Defamation Suit Targets Attorney Tony Buzbee and Jane Doe
Next post Suzuki Swift voted Best Budget Car at 2025 Cars.co.za Consumer Awards